Difference between revisions of "Male Feminising Syndrome"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
| − | |||
Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation. | Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation. | ||
| Line 7: | Line 6: | ||
*Methyltestosterone. | *Methyltestosterone. | ||
| − | + | [[Category:To Do - Reproductive]] | |
[[Category:Endocrine System - Pathology]] | [[Category:Endocrine System - Pathology]] | ||
[[Category:Reproductive System - Pathology]] | [[Category:Reproductive System - Pathology]] | ||
Revision as of 18:49, 12 April 2011
Clinical signs mimic sertoli cell tumour with similar skin changes. In this case both testes will be normal in appearance and texture. Gynaecomastia is a constant finding, in contrast to sertoli cell tumour where less than 40% may show feminisation.
Treatment:
- Castration.
- Anti-seborrhoeic shampoo.
- Methyltestosterone.